G

Genexine Inc
KOSDAQ:095700

Watchlist Manager
Genexine Inc
KOSDAQ:095700
Watchlist
Price: 4 985 KRW 2.47% Market Closed
Market Cap: 227B KRW

Operating Margin
Genexine Inc

-2 805.5%
Current
-919%
Average
-5.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-2 805.5%
=
Operating Profit
-33.1B
/
Revenue
1.2B

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
KR
Genexine Inc
KOSDAQ:095700
226.7B KRW
-2 806%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
346.7B USD
30%
US
Amgen Inc
NASDAQ:AMGN
161.1B USD
25%
US
Gilead Sciences Inc
NASDAQ:GILD
141.8B USD
38%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.4B USD
38%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
AU
CSL Ltd
ASX:CSL
117.4B AUD
26%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
60.7B USD
29%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
42.1B USD
-5%

Genexine Inc
Glance View

Market Cap
226.7B KRW
Industry
Biotechnology

Genexine, Inc. engages in research and development of therapeutic vaccines hybrid Fc fusion proteins (hyFc) and DNA (deoxyribonucleic acid) therapeutic vaccines. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2009-09-15. The firm operates its business through two segments. The New Drug Development segment engages in human growth hormone, neutropenia treatment, anemia treatment, anticancer immunotherapy, hyFc platform, and other technology transfers. In addition, this segment sells the technical property rights of follicle-stimulating hormone. The company also engages in cell line construction and sample production, project development, animal testing, human growth hormone development, and government agency research. The Medical Consumables segment produces and sells medical consumables such as medicine bags.

Intrinsic Value
247.38 KRW
Overvaluation 95%
Intrinsic Value
Price
G
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-2 805.5%
=
Operating Profit
-33.1B
/
Revenue
1.2B
What is the Operating Margin of Genexine Inc?

Based on Genexine Inc's most recent financial statements, the company has Operating Margin of -2 805.5%.

Back to Top